PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 48 filers reported holding PROQR THRAPEUTICS N V in Q4 2020. The put-call ratio across all filers is 13.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $67,000 | -89.8% | 73,790 | -10.4% | 0.00% | -85.7% |
| Q4 2021 | $660,000 | +10.0% | 82,338 | -9.2% | 0.01% | +16.7% |
| Q1 2021 | $600,000 | +59.6% | 90,714 | +1.3% | 0.01% | +50.0% |
| Q4 2020 | $376,000 | +22.9% | 89,562 | +40.1% | 0.00% | -20.0% |
| Q3 2020 | $306,000 | -26.1% | 63,947 | -6.2% | 0.01% | -16.7% |
| Q2 2020 | $414,000 | -7.2% | 68,166 | -12.0% | 0.01% | +100.0% |
| Q3 2019 | $446,000 | -39.7% | 77,479 | -4.8% | 0.00% | -40.0% |
| Q2 2019 | $740,000 | – | 81,350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,237,400 | $5,197,000 | 1.55% |
| Prosight Management, LP | 255,000 | $1,071,000 | 0.50% |
| RTW INVESTMENTS, LP | 5,009,768 | $21,041,000 | 0.35% |
| Kerrisdale Advisers, LLC | 453,182 | $1,903,000 | 0.15% |
| Artal Group S.A. | 1,196,218 | $5,024,000 | 0.11% |
| COWEN AND COMPANY, LLC | 285,696 | $1,200,000 | 0.11% |
| Golden Green, Inc. | 16,999 | $71,000 | 0.07% |
| APOGEM CAPITAL LLC | 15,855 | $67,000 | 0.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $19,110,000 | 0.04% |
| ALTRINSIC GLOBAL ADVISORS LLC | 241,360 | $1,014,000 | 0.03% |